These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 6690943)
1. A proposed new role for the insurance industry in biomedical research funding. Kahn CR N Engl J Med; 1984 Jan; 310(4):257-8. PubMed ID: 6690943 [No Abstract] [Full Text] [Related]
2. The NIH, research institutions and industry: working together on a shared goal. Omary MB Gastroenterology; 2007 May; 132(5):1647-50. PubMed ID: 17484859 [No Abstract] [Full Text] [Related]
3. Insurance industry and biomedical research. N Engl J Med; 1984 Jun; 310(25):1674-5. PubMed ID: 6727945 [No Abstract] [Full Text] [Related]
4. Accidents and health premiums 1985. Hall RL Bests Rev Life Health Insur Ed; 1986 Dec; 87(8):92-9. PubMed ID: 10279585 [No Abstract] [Full Text] [Related]
5. The future of research funding in academic medicine. Campbell EG N Engl J Med; 2009 Apr; 360(15):1482-3. PubMed ID: 19357403 [No Abstract] [Full Text] [Related]
6. Who should be responsible? Brown E Physician Exec; 1996 Jun; 22(6):38-9. PubMed ID: 10158532 [No Abstract] [Full Text] [Related]
7. A proposal for funding clinical research trials by health care insurers. Paller MS J Investig Med; 1997 Apr; 45(4):139-42. PubMed ID: 9154293 [No Abstract] [Full Text] [Related]
8. Revitalizing the federal commitment in support of biomedical research. Hathaway DR Clin Res; 1988 Sep; 36(5):475-82. PubMed ID: 3168401 [No Abstract] [Full Text] [Related]
9. Evaluation of medical-technology strategies: proposal for an institute for health-care evaluation (second of two parts). Bunker JP; Fowles J; Schaffarzick R N Engl J Med; 1982 Mar; 306(11):687-92. PubMed ID: 7035949 [No Abstract] [Full Text] [Related]
10. Addressing the decline in NIH pain research funding. Max MB J Pain; 2008 Dec; 9(12):1074-6. PubMed ID: 19038769 [No Abstract] [Full Text] [Related]
11. A lost generation. Weinberg RA Cell; 2006 Jul; 126(1):9-10. PubMed ID: 16839866 [TBL] [Abstract][Full Text] [Related]
12. The gang of four: how does the growth of life settlements affect the life insurance industry? Nowlan WJ J Insur Med; 2007; 39(1):28-32. PubMed ID: 17500354 [No Abstract] [Full Text] [Related]
13. Research funding. NIH in the post-doubling era: realities and strategies. Zerhouni EA Science; 2006 Nov; 314(5802):1088-90. PubMed ID: 17110557 [No Abstract] [Full Text] [Related]
14. Justifying government as the backstop in health insurance markets. Swartz K Yale J Health Policy Law Ethics; 2001; 2(1):89-108. PubMed ID: 12664938 [No Abstract] [Full Text] [Related]
15. Technology development from the perspective of industry. Abele JE J Invasive Cardiol; 1993 Mar; 5(2):65-8. PubMed ID: 10171667 [No Abstract] [Full Text] [Related]
16. Health Policy report. Moment of truth for the teaching hospitals. Iglehart JK N Engl J Med; 1982 Jul; 307(2):132-6. PubMed ID: 7201075 [No Abstract] [Full Text] [Related]
17. Perverted priorities. The physician/scientist as spokesman and salesman for biomedical research. Presidential address to the American Society for Clinical Investigation, Washington, DC, 29 April 1989. Kahn CR J Clin Invest; 1989 Sep; 84(3):723-7. PubMed ID: 2668339 [No Abstract] [Full Text] [Related]
18. 2 separate programs are involved in Canada's health insurance plan. Allison T Rev Fed Am Hosp; 1978 Aug; 11(5):16-21. PubMed ID: 10308081 [No Abstract] [Full Text] [Related]
19. Medical research funding: a series of crises. Beaven DW N Z Med J; 1986 Feb; 99(795):53-4. PubMed ID: 3456110 [No Abstract] [Full Text] [Related]
20. Funding for Canadian biomedical research - a ray of hope! Jamali F J Pharm Pharm Sci; 1998; 1(2):47. PubMed ID: 10945917 [No Abstract] [Full Text] [Related] [Next] [New Search]